What is Mounjaro Used for Besides Weight Loss?

Last reviewed: July 11, 2026

Last updated: July 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, marketed as Mounjaro, functions as a dual GLP-1 and GIP receptor agonist that addresses multiple metabolic pathways beyond appetite suppression. The medication was approved by the FDA in 2022 specifically for glycemic control in adults with type 2 diabetes, with clinical trials demonstrating reductions in hemoglobin A1c levels ranging from 1.5% to 2.2% depending on dose. Understanding tirzepatide's full spectrum of therapeutic applications helps patients and providers make informed decisions about whether this medication aligns with their health goals.

Tirzepatide for Type 2 Diabetes Management

Tirzepatide's primary FDA indication is treating type 2 diabetes in adults who cannot achieve adequate glycemic control through diet and exercise alone. The medication works by stimulating both GLP-1 and GIP receptors in the pancreas, which increases insulin secretion when blood glucose rises and reduces glucagon release when glucose is low. Clinical trials showed that tirzepatide reduced fasting blood glucose by 30-40 mg/dL and lowered HbA1c in patients ranging from those newly diagnosed to those with long-standing disease.

Patients using tirzepatide for diabetes often experience improved insulin sensitivity, meaning their cells respond more effectively to available insulin. This improved metabolic response can reduce the burden on the pancreas and slow the progression of insulin resistance over time. Many people with type 2 diabetes who start tirzepatide are able to reduce or discontinue other glucose-lowering medications under medical supervision, simplifying their treatment regimen.

Cardiovascular Benefits Beyond Blood Sugar Control

Research published in major cardiovascular journals demonstrates that tirzepatide reduces the risk of major adverse cardiac events in patients with type 2 diabetes and established heart disease. The medication's cardiovascular benefits appear to stem from multiple mechanisms: improved glucose metabolism, reduced inflammation markers like C-reactive protein, and modest reductions in systolic blood pressure averaging 3-5 mmHg. These effects combine to lower overall cardiovascular mortality risk, making tirzepatide valuable for patients whose primary concern is heart health rather than weight alone.

Tirzepatide also helps reduce triglyceride levels, a lipid marker strongly associated with cardiovascular disease risk. Patients with diabetes often struggle with elevated triglycerides despite statin therapy, but tirzepatide can achieve 15-20% reductions in some populations. This combination of benefits—improved glucose control, lower blood pressure, reduced inflammation, and improved lipid profiles—makes tirzepatide a comprehensive metabolic therapy rather than a single-purpose medication.

Anti-Inflammatory Effects and Metabolic Health

Beyond glucose and weight management, tirzepatide appears to have systemic anti-inflammatory properties that benefit overall metabolic health. Studies measure inflammation through biomarkers like C-reactive protein and IL-6, and tirzepatide consistently lowers these markers even after accounting for weight loss. This anti-inflammatory effect may protect against chronic diseases associated with elevated inflammation, including certain cancers, autoimmune conditions, and neurodegenerative disorders, though more research is ongoing in these areas.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How PlexusDx Personalizes Tirzepatide Therapy

PlexusDx offers compounded tirzepatide injections starting at $289/mo (or $249/mo on the 6-month plan) through licensed 503A compounding pharmacies, making this therapy accessible without insurance or membership requirements. The medication is HSA/FSA eligible, providing additional savings flexibility for patients managing multiple health conditions. PlexusDx serves all 50 states and adjusts medication protocols based on individual response and tolerability, ensuring each patient receives optimized therapy for their specific health goals.

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I use tirzepatide if I don't have type 2 diabetes?

While tirzepatide's primary FDA indication is type 2 diabetes, compounded tirzepatide prescribed by licensed physicians may be used off-label for other metabolic conditions. PlexusDx works with providers to ensure tirzepatide aligns with individual health needs and clinical circumstances, whether that's diabetes prevention, cardiovascular risk reduction, or other metabolic goals.

How does tirzepatide differ from semaglutide for non-diabetes uses?

Tirzepatide activates both GLP-1 and GIP receptors, providing dual metabolic effects, whereas semaglutide targets GLP-1 alone. This dual mechanism often produces stronger glucose control and cardiovascular benefits in diabetes patients, though PlexusDx offers both options because individual genetic predispositions and health goals determine which medication is best suited for each person.

What does PlexusDx charge for tirzepatide injections?

PlexusDx compounded tirzepatide injections start at $289/mo (or $249/mo on the 6-month plan)—your dose may need to go up, but your price won't. The medication is provided through licensed 503A compounding pharmacies, is HSA/FSA eligible, and requires no insurance or membership fee.

Are there risks to using tirzepatide for conditions other than diabetes?

Tirzepatide carries the same potential side effects across all indications, most commonly nausea, vomiting, and diarrhea during dose escalation. Serious but rare risks include pancreatitis and thyroid concerns; patients should be monitored by their healthcare provider. PlexusDx ensures prescribing physicians assess individual risk factors and contraindications before starting therapy.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.